Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Acurx Pharmaceuticals Inc ACXP

Healthcare Biotechnology
Acurx Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. It develops antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC... see more

Bullboard (NDAQ:ACXP)

View:
User Avatar Image
(276)
•••
  • whytestocksX
Post by whytestockson Oct 28, 2024 3:16pm

New to The Street on Fox Business Premieres Exclusive Sponso

BREAKING NEWS: $ACXP New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath ...more  
38
User Avatar Image
(9)
•••
  • MikeTesterX
Post by MikeTesteron Aug 03, 2024 11:06am

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP): A Promising Antib

https://beyondspx.com/2024/08/02/acurx-pharmaceuticals-inc-nasdaqacxp-a-promising-antibiotic-candidate-targeting-a-billion-dollar-market/
37
User Avatar Image
(276)
•••
  • whytestocksX
Post by whytestockson Feb 23, 2024 9:45pm

New to The Street Announces Line-up of its Corporate Intervi

JUST IN: $ACXP New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series | BenzingaNEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- FMW Media ...more  
85
User Avatar Image
(276)
•••
  • whytestocksX
Post by whytestockson Feb 16, 2024 4:15pm

New to The Street Airs Episode 556 Featuring Five Corporate

News; $ACXP New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PTNEW YORK, Feb. 16, 2024 (GLOBE ...more  
79
User Avatar Image
(3)
•••
  • mattusviX
Post by mattusvion Jan 04, 2022 9:21am

Ibezapolstat Takes Center Stage

https://www.marketwatch.com/press-release/acurx-pharmaceuticals-ibezapolstat-takes-center-stage-after-summit-therapeutics-misses-phase-3-cdiff-trial-endpoints-nasdaq-acxp-2022-01-03 Acurx ...more  
169